How We Treat Mycosis Fungoides and Sezary Syndrome

被引:0
|
作者
Khan, Niloufer [1 ]
Noor, Sarah J. [2 ]
Horwitz, Steven [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY 10021 USA
关键词
T-CELL LYMPHOMA; ELECTRON-BEAM THERAPY; LOW-DOSE METHOTREXATE; QUALITY-OF-LIFE; PHASE-II; INTERNATIONAL-SOCIETY; EUROPEAN-ORGANIZATION; CUTANEOUS-LYMPHOMAS; CONSENSUS STATEMENT; MULTICENTER-TRIAL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:573 / 581
页数:9
相关论文
共 50 条
  • [31] The utility of bexarotene in mycosis fungoides and Sezary syndrome
    Panchal, Manisha R.
    Scarisbrick, Julia J.
    ONCOTARGETS AND THERAPY, 2015, 8 : 367 - 373
  • [32] Immunological milieu in mycosis fungoides and Sezary syndrome
    Miyagaki, Tomomitsu
    Sugaya, Makoto
    JOURNAL OF DERMATOLOGY, 2014, 41 (01): : 11 - 18
  • [33] How should we treat MYCOSIS FUNGOIDES in the frail older adult?
    Patel, P.
    Nurpeisov, V.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S28 - S28
  • [34] Evaluation of Alitretinoin for the Treatment of Mycosis Fungoides and Sezary Syndrome
    Alhusayen, Raed
    Trang Tuyet Vu
    Almuhanna, Nouf
    Wohlmuth-Wieser, Iris
    Hardin, Jori
    Hughes, John-Douglas Matthew
    Chia, Justin
    Street, Leslie
    Shear, Neil Hartley
    Walsh, Scott Richard
    Gniadecki, Robert
    DERMATOLOGY, 2021, 237 (03) : 479 - 485
  • [35] Prognostic factor analysis in mycosis fungoides/Sezary syndrome
    Diamandidou, E
    Colome, M
    Fayad, L
    Duvic, M
    Kurzrock, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (06) : 914 - 924
  • [36] New trends in the management of mycosis fungoides and Sezary syndrome
    Batycka-Baran, Aleksandra
    Reich, Adam
    Jankowska-Konsur, Alina
    Maj, Joanna
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2009, 26 (01): : 41 - 55
  • [37] Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sezary Syndrome
    Zic, John A.
    DERMATOLOGIC CLINICS, 2015, 33 (04) : 765 - +
  • [38] Alemtuzumab in patients with advanced mycosis fungoides and Sezary syndrome
    Beltran-Garate, Brady
    Gomez, Henry
    Lopez, Jose L.
    Borrego, Mildred
    Prieto, Mercedes
    Carrasco-Yalan, Antonio A.
    Huamani, Julia
    Castillo, Jorge
    Da Costa, Osiris
    BLOOD, 2007, 110 (11) : 1003A - 1004A
  • [39] EORTC guidelines for the treatment of Mycosis Fungoides/Sezary Syndrome
    Knobler, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : S11 - S11
  • [40] Quality of life of patients with mycosis fungoides and Sezary syndrome
    Jaeger, Manuel
    Oezistanbullu, Deniz
    Klemke, Claus-Detlev
    Tratzmiller, Sabine
    DERMATOLOGIE, 2022, 73 (10): : 759 - 764